Skip to main content

Table 2 HRQOL and treatment satisfaction

From: Continuous intraperitoneal insulin infusion in type 1 diabetes: a 6-year post-trial follow-up

 

Start 2006 study (A)

End SC phase (B)

End CIPII phase (C)

2012 study (D)

D vs. A

D vs. B

D vs. C

SF-36 subscales

       

Physical functioning

76 (66, 86)

69 (59, 79)

81 (71, 91)

76 (65, 86)

-0.3 (-19.7, 19.1)

7.4 (-12.1, 26.8)

-5.3 (-24.7, 14.1)

Social functioning

68 (53, 76)

65 (53, 76)

77 (66, 88)

74 (63, 85)

6.6 (-14.7, 27.8)

9.9 (-11.4, 31.2)

-2.6 (-32.9, 18.6)

Role limitations-physical

38 (17, 59)

42 (21, 63)

66 (45, 87)

57 (36, 78)

18.4 (-22.0, 58.8)

14.5 (-26.0, 54.9)

-9.2 (-49.6, 31.2)

Role limitations-emotional

68 (50, 87)

68 (50, 87)

86 (67, 100)

77 (58, 96)

8.8 (-27.3, 44.8)

8.8 (-27.3, 44.8)

-8.8 (-44.8, 27.3)

Mental health

70 (60, 79)

67 (58, 77)

77 (68, 87)

79 (70, 89)

9.6 (-8.1, 27.4)

12.0 (-5.8, 29.7)

2.1 (-15.7, 19.8)

Vitality

48 (39, 58)

43 (34, 71)

62 (52, 71)

58 (49, 67)

9.5 (-7.9, 26.9)

15.3 (-2.2, 32.7)

-4.5 (-32.9, 12.8)

Bodily pain

64 (52, 75)

64 (53, 76)

66 (54, 77)

67 (56, 78)

3.3 (-18.5, 25.0)

2.6 (-19.2, 24.3)

1.4 (-20.4, 23.1)

General health

41 (32, 50)

46 (37, 54)

56 (47, 64)

48 (38, 56)

6.5 (-10.1, 23.1)

1.7 (-14.9, 18.3)

-8.0 (-24.7, 8.6)

SF-36 summary scores

       

Physical component score

56 (46, 65)

55 (45, 64)

68 (58, 77)

63 (54, 73)

7.3 (-10.9, 25.6)

8.5 (-9.7, 26.8)

-4.7 (-23.0, 13.5)

Mental component score

59 (50, 68)

58 (49, 67)

72 (63, 81)

67 (58, 76)

8.2 (-9.1, 25.5)

9.5 (-7.7, 26.8)

-4.4 (-21.6, 12.9)

WHO-5 score

49 (39, 59)

47 (37, 57)

69 (59, 79)

60 (50, 70)

10.5 (-9.0, 30.0)

12.6 (-6.9, 32.1)

-9.2 (-28.8, 10.2)

DTSQ

       

Total score

24 (21, 27)

24 (21, 27)

33 (30, 36)

33 (29, 36)

8.3 (2.3, 14.3)*

8.4 (2.4,14.3)*

-0.3 (-6.3, 5.7)

Perceived hypoglycaemia score

5 (4, 6)

5 (4, 5)

2 (2, 3)

4 (3, 5)

-0.4 (-2.0, 1.2)

-0.8 (-2.4, 0.8)

0.3 (-1.3, 1.9)

Perceived hyperglycaemia score

3 (2, 4)

4 (3, 5)

3 (2, 3)

3 (2, 4)

-1.1 (-2.4, 0.1)

-0.9 (-2.1, 0.3)

1.5 (0.2, 2.7)*

  1. Estimated values and differences are reported. Data are presented as estimated mean (95% CI) or mean change (95% CI). Numbers may not add up due to rounding. DTSQ; Diabetes Treatment Satisfaction Questionnaire, CIPII; continuous intraperitoneal insulin infusion, SC; subcutaneous, SF-36; 36-item short-form health survey, WHO-5; World Health Organization-Five Well-Being Index *p < 0.05.